These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6773953)

  • 1. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.
    Steinmann B; Tuderman L; Peltonen L; Martin GR; McKusick VA; Prockop DJ
    J Biol Chem; 1980 Sep; 255(18):8887-93. PubMed ID: 6773953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
    Stolle CA; Pyeritz RE; Myers JC; Prockop DJ
    J Biol Chem; 1985 Feb; 260(3):1937-44. PubMed ID: 2981879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
    Chiodo AA; Hockey A; Cole WG
    J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII.
    Cole WG; Chan D; Chambers GW; Walker ID; Bateman JF
    J Biol Chem; 1986 Apr; 261(12):5496-503. PubMed ID: 3082886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
    Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
    Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
    Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
    J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
    Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
    J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
    Eyre DR; Shapiro FD; Aldridge JF
    J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
    Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
    Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
    Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
    J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
    Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
    Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existence of malfunctioning pro alpha2(I) collagen genes in a patient with a pro alpha 2(I)-chain-defective variant of Ehlers-Danlos syndrome.
    Hata R; Kurata S; Shinkai H
    Eur J Biochem; 1988 Jun; 174(2):231-7. PubMed ID: 3383844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations that alter the primary structure of type I procollagen have long-range effects on its cleavage by procollagen N-proteinase.
    Dombrowski KE; Vogel BE; Prockop DJ
    Biochemistry; 1989 Aug; 28(17):7107-12. PubMed ID: 2684272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.
    Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F
    J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide.
    Holmes DF; Watson RB; Steinmann B; Kadler KE
    J Biol Chem; 1993 Jul; 268(21):15758-65. PubMed ID: 8340401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
    Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K
    Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen.
    Sasaki T; Arai K; Ono M; Yamaguchi T; Furuta S; Nagai Y
    Arch Dermatol; 1987 Jan; 123(1):76-9. PubMed ID: 3800425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
    Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
    Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.
    Vasan NS; Kuivaniemi H; Vogel BE; Minor RR; Wootton JA; Tromp G; Weksberg R; Prockop DJ
    Am J Hum Genet; 1991 Feb; 48(2):305-17. PubMed ID: 1990839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.